作者: Hossein Jadvar , Bhushan Desai , Peter S. Conti
DOI: 10.1053/J.SEMNUCLMED.2014.07.008
关键词:
摘要: The use of 18 F-sodium fluoride ( F-NaF) with PET/CT is increasing. This resurgence an old tracer has been fueled by several factors including superior diagnostic performance over standard 99m Tc-based bone scintigraphy, growth in the availability imaging systems, increase number regional commercial distribution centers for PET radiotracers, recent concerns about potential recurring shortages and decision Centers Medicare Medicaid Services to reimburse F-NaF evaluation patients known or suspected metastases through National Oncologic Registry. major goal this article review current evidence on utility assessment joint a variety clinical conditions.